Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette–Guérin immunotherapy on the outcome

References

• Wolf H, Olsen PR, Fischer A, Hojgaard K. Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients. Scand J Urol Nephrol 1987;21:33–8.
   PubMed Web of Science ®Google Scholar
• Norming U, Nyman CR, Tribukait B. Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma. J Urol 1991;145:1164–8.
   PubMed Web of Science ®Google Scholar
• Murphy WM, Busch C, Algaba F. Intraepithelial lesions of urinary bladder: morphologic considerations. Scand J Urol Nephrol Suppl 2000;67–81.
   PubMedGoogle Scholar
• Lamm D, Herr H, Jakse G, Kuroda M, Mostofi FK, Okajima E, Updated concepts and treatment of carcinoma in situ. Urol Oncol 1998;4:130–8.
   PubMedGoogle Scholar
• Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999;85:2469–74.
   PubMed Web of Science ®Google Scholar
• Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette–Guerin in the treatment of superficial bladder tumors. J Urol 1976;116:180–3.
   PubMed Web of Science ®Google Scholar
• Herr HW, Pinsky CM, Whitmore WF Jr, Sogani PC, Oettgen HF, Melamed MR. Long-term effect of intravesical bacillus Calmette–Guerin on flat carcinoma in situ of the bladder. J Urol 1986;135:265–7.
   PubMed Web of Science ®Google Scholar
• Chade DC, Shariat SF, Adamy A, Bochner BH, Donat SM, Herr HW, Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 2010;184:464–9.
   PubMed Web of Science ®Google Scholar
• Sylvester RJ, van der Meijden AP, Witjes JA, Kurth K. Bacillus Calmette–Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 2005;174:86–91.
   PubMed Web of Science ®Google Scholar
• Griffiths TR, Charlton M, Neal DE, Powell PH. Treatment of carcinoma in situ with intravesical bacillus Calmette–Guerin without maintenance. J Urol 2002;167:2408–12.
   PubMed Web of Science ®Google Scholar
• Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997;158:62–7.
   PubMed Web of Science ®Google Scholar
• Sylvester RJ, van der Meijden AP, Witjes JA, Jakse G, Nonomura N, Cheng C, High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 2005;66:90–107.
   PubMed Web of Science ®Google Scholar
• Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010;57:595–606.
   PubMed Web of Science ®Google Scholar
• Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical–pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965;130:371–8.
   PubMedGoogle Scholar
• Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 2010;58:185–90.
   PubMed Web of Science ®Google Scholar
• Zieger K, Olsen PR, Wolf H, Hojgaard K. Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia – recurrence and progression. Scand J Urol Nephrol 2002;36:52–9.
   PubMed Web of Science ®Google Scholar
• Orozco RE, Martin AA, Murphy WM. Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis. Cancer 1994;74:115–22.
   PubMed Web of Science ®Google Scholar
• Jakse G, Hall R, Bono A, Holtl W, Carpentier P, Spaander JP, Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861. Eur Urol 2001;40:144–50.
   PubMed Web of Science ®Google Scholar
• Takenaka A, Yamada Y, Miyake H, Hara I, Fujisawa M. Clinical outcomes of bacillus Calmette–Guerin instillation therapy for carcinoma in situ of urinary bladder. Int J Urol 2008;15:309–13.
   PubMed Web of Science ®Google Scholar
• Andius P, Damm O, Holmang S. Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette–Guerin. Scand J Urol Nephrol 2004;38:285–90.
   PubMed Web of Science ®Google Scholar
• Kaasinen E, Wijkstrom H, Malmstrom PU, Hellsten S, Duchek M, Mestad O, Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a Nordic study. Eur Urol 2003;43:637–45.
   PubMed Web of Science ®Google Scholar
• Zieger K, Marcussen N, Borre M, Orntoft TF, Dyrskjot L. Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development. Int J Cancer 2009;125:2095–103.
   PubMed Web of Science ®Google Scholar
• Junker K, van Oers JM, Zwarthoff EC, Kania I, Schubert J, Hartmann A. Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations. Neoplasia 2008;10:1–7.
   PubMed Web of Science ®Google Scholar
• van Rhijn BW, van der Kwast TH, Vis AN, Kirkels WJ, Boeve ER, Jobsis AC, FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Res 2004;64:1911–4.
   PubMed Web of Science ®Google Scholar
• Solsona E, Iborra I, Ricos JV, Monros JL, Dumont R, Almenar S. Extravesical involvement in patients with bladder carcinoma in situ: biological and therapy implications. J Urol 1996;155:895–9.
   PubMed Web of Science ®Google Scholar
• Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 1998;16:1099–102.
   PubMed Web of Science ®Google Scholar
• Liedberg F, Chebil G, Mansson W. Urothelial carcinoma in the prostatic urethra and prostate: current controversies. Expert Rev Anticancer Ther 2007;7:383–90.
   PubMed Web of Science ®Google Scholar